Oxytocin formulations ban to come into effect from July 1, 2018

KAPL to manufacture the drug for domestic use only

The Ministry of Health and Family Welfare (MoH&FW) has restricted the manufacture of oxytocin formulations for domestic use to public sector only from July 1, 2018. It has also banned the import of oxytocin and its formulations.

From July 1, 2018, no private manufacturers will be allowed to manufacture the drug for domestic use. Only Karnataka Antibiotics & Pharmaceuticals Ltd (KAPL), a public sector company, would be manufacturing this drug for domestic use from that date. The oxytocin formulations meant for domestic consumption will be supplied by the manufacturer, i.e. KAPL, to the registered hospitals and clinics in public and private sector directly. Oxytocin in any form or name will not be allowed to be sold through retail chemist.

All registered hospitals and clinics in public and private sector in the country are advised by MoH&FW to contact KAPL and place their orders with the company as the drug will not be available with retail chemists or any other manufacturer.